IL10 and neoplasm: Several tumour-derived products present in sera and tumour extracts from cancer patients, including transforming growth factor β (tgfβ), prostaglandin E2, interleukin-10, and vascular endothelial growth factor 1–4, have been identified and employ a variety of mechanisms to promote tumour growth.